Findings from a recent study showed potential associations between psoriasis, comorbid conditions, and sexual and erectile dysfunction among patients with this skin condition.

News

News
Thursday, May 26, 2016
A recent study evaluated detailed drug utilization in patients with psoriasis compared with controls in a population-based sample.
News
Monday, May 23, 2016
The open-label extension (OLE) study evaluated the long-term safety and efficacy of etanercept (Enbrel) for pediatric psoriasis. 
News
Friday, May 20, 2016
The Corrona Psoriasis Registry will track the drug safety reporting for ixekizumab (Taltz), a new biologic medication by Eli Lilly and Company that was recently FDA approved for the treatment of moderate to severe plaque psoriasis.